Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: A multicenter, single-arm, phase II, open-label clinical trial

by biblioteca on 16 de març de 2026 with No hi ha comentaris

Elez, E., Siena, S., Sartore-Bianchi, A., Ros, J., Ciardello, F., Martinelli, E., Steeghs, N., Huijberts, S., Cervantes, A., Roselló, S., Tejpar, S., Wilmsen, B., Salazar, R., Santos, C., de Schaetzen, G., Muñoz, S., Bernards, R., Moreno, V., García-Galera, E., … Dienstmann R., … Tabernero, J. (2025). Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: A multicenter, single-arm, phase II, open-label clinical trial. ESMO Open, 10(12), Article 105892. https://doi.org/10.1016/j.esmoop.2025.105892